The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Knutzen Steuer, K. L.
Right arrow Articles by Atkinson, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knutzen Steuer, K. L.
Right arrow Articles by Atkinson, J. P.

The Journal of Immunology, Vol 143, Issue 7 2256-2261, Copyright © 1989 by American Association of Immunologists

ARTICLES

Lysis of sensitized sheep erythrocytes in human sera deficient in the second component of complement

KL Knutzen Steuer, LB Sloan, TJ Oglesby, TC Farries, MW Nickells, P Densen, JB Harley and JP Atkinson
Howard Hughes Medical Institute Laboratories, Washington University School of Medicine, St. Louis, MO 63110.

Analysis of C-dependent lysis of sensitized SRBC by C2-deficient sera (C2D) led to the characterization of a C2 bypass pathway. Lysis in the total hemolytic C assay by C2D sera was Ca2+-dependent and required a high concentration of hemolysin to sensitize E. Selective component depletion indicated a requirement for C1 and C4 of the classical pathway (CP) and proteins B, P, and probably D of the alternative pathway (AP). Total hemolytic C could be restored to normal in these C2D sera by utilizing heavily sensitized E or by the addition of a supranormal concentration of B. This system most closely resembles a pathway described by J. E. May and M. M. Frank which requires antibody, C1, and the AP but not C4 or C2. It differs in its requirement for C4. We hypothesize that this pathway represents vestiges of a more primitive C pathway. It becomes evident and possibly clinically important in the setting of C2 deficiency, by allowing C activation, other than the AP, and perhaps in normal individuals, by damaging microorganisms that have evolved means to inhibit early components of the CP.


This article has been cited by other articles:


Home page
 Infect. Immun.Home page
I. Celik, C. Stover, M. Botto, S. Thiel, S. Tzima, D. Kunkel, M. Walport, W. Lorenz, and W. Schwaeble
Role of the Classical Pathway of Complement Activation in Experimentally Induced Polymicrobial Peritonitis
Infect. Immun., December 1, 2001; 69(12): 7304 - 7309.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. Wagner, J. L. Platt, D. N. Howell, H. C. Marsh Jr., and M. M. Frank
IgG and Complement-Mediated Tissue Damage in the Absence of C2: Evidence of a Functionally Active C2-Bypass Pathway in a Guinea Pig Model
J. Immunol., September 15, 1999; 163(6): 3549 - 3558.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.